Driving Biomedical Innovation” is one of the signature initiatives of the Obama Administration and of US Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg's tenure at the agency.1 This initiative embodies administration policies that government should encourage growth and innovation rather than being the stifling blanket of bureaucracy and delay so often cited by critics of government regulation. Prominent in the agency-wide initiative is the FDA's program for speeding approval of seemingly promising new drugs, known officially as the “Expedited Drug Development Pathway.”1
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 6
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.